Sarepta Therapeutics, Inc. SRPT Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s other working capital?
- Sarepta Therapeutics, Inc. (SRPT) reported other working capital of $1.29M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s other working capital changed year-over-year?
- Sarepta Therapeutics, Inc.'s other working capital increased by 394.1% year-over-year, from -$438K to $1.29M.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.